Philadelphia, Pennsylvania, United States – May 2025 – Minaris Advanced Therapies, a leading global CDMO focused on cell and gene therapies, has announced the appointment of Kaia Boyd as Chief Human Resources Officer (CHRO). In this strategic leadership role, Kaia will spearhead the company’s global HR agenda, driving organizational effectiveness, people strategy, and cultural alignment across operations in the United States, Europe, and Asia.
Kaia joins Minaris Advanced Therapies with over two decades of progressive HR leadership experience across life sciences, consulting, and retail industries. Most recently, she served as Founder & Owner of People Centric Consulting Services, where she advised private equity firms and startups on strategic HR integration and performance systems.
Prior to that, Kaia was Sr. Director, People & Culture at Societal™ CDMO, where she led HR transformation efforts, including HCM implementation and organizational restructuring. She also held senior HR roles at Ajinomoto Bio-Pharma Services, where she oversaw rapid organizational growth, employee engagement initiatives, and compensation frameworks.
Kaia’s earlier career includes over 10 years with Macy’s, where she honed her expertise in employee engagement, performance coaching, and succession planning. Her proven ability to lead through change, align HR strategy with business objectives, and foster high-performing teams will be pivotal to Minaris’ continued growth and global operations.
About Minaris Advanced Therapies
Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider dedicated exclusively to cell and gene therapies. With more than 730,000 square feet of infrastructure across North America, Europe, and Asia, and a track record of 7,500+ GMP batches, the company supports therapy developers from early-stage development through to commercial manufacturing. Minaris is known for delivering high-quality, scalable, and cost-effective solutions backed by two decades of expertise in regenerative medicine. Minaris Advanced Therapies is wholly owned by Altaris, LLC.
Read Also : HR Is Not a Support Function—It’s the CEO’s Most Powerful Growth Engine
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
From Gatekeeping to Gateway Building: Transforming How Organisations Create Access
Leadership In Talent Management: A Powerful Driver for Economic Growth
